Biomarker studies: a call for a comprehensive biomarker study registry

Fabrice Andre,Lisa M. McShane,Stefan Michiels,David F. Ransohoff,Douglas G. Altman,Jorge S. Reis-Filho,Daniel F. Hayes,Lajos Pusztai
DOI: https://doi.org/10.1038/nrclinonc.2011.4
IF: 78.8
2011-03-01
Nature Reviews Clinical Oncology
Abstract:Publication bias and hidden multiple hypotheses testing distort the assessment of the true value of biomarkers. The authors of this article propose that a registry should be created for biomarker studies initially focused on studies that use specimens from randomized trials, as a means to alleviate the limitations associated with both publication bias and multiple hypotheses testing.
oncology
What problem does this paper attempt to address?